AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure - a substudy to the MERIT-HF trial
Authors: Gullestad, L Manhenke, C Aarsland, T Skardal, R Fagertun, H Wikstrand, J Kjekshus, J
Citation: L. Gullestad et al., Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure - a substudy to the MERIT-HF trial, EUR J HE FA, 3(4), 2001, pp. 463-468
Inflammatory role of platelets in acute coronary syndromes
Authors: Aukrust, P Waehre, T Damas, JK Gullestad, L Solum, NO
Citation: P. Aukrust et al., Inflammatory role of platelets in acute coronary syndromes, HEART, 86(6), 2001, pp. 605-606
Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure - Modulatory effect of intravenous immunoglobulin
Authors: Damas, JK Gullestad, L Aass, H Simonsen, S Fjeld, JG Wikeby, L Ueland, T Eiken, HG Froland, SS Aukrust, P
Citation: Jk. Damas et al., Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure - Modulatory effect of intravenous immunoglobulin, J AM COL C, 38(1), 2001, pp. 187-193
Interaction between chemokines and oxidative stress: Possible pathogenic role in acute coronary syndromes
Authors: Aukrust, P Berge, RK Ueland, T Aaser, E Damas, JK Wikeby, L Brunsvig, A Muller, F Forfang, K Froland, SS Gullestad, L
Citation: P. Aukrust et al., Interaction between chemokines and oxidative stress: Possible pathogenic role in acute coronary syndromes, J AM COL C, 37(2), 2001, pp. 485-491
Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes
Authors: Damas, JK Aukrust, P Ueland, T Odegaard, A Eiken, HG Gullestad, L Sejersted, OM Christensen, G
Citation: Jk. Damas et al., Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes, BAS R CARD, 96(4), 2001, pp. 345-352
Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients
Authors: Holm, T Andreassen, AK Aukrust, P Andersen, K Geiran, OR Simonsen, S Gullestad, L
Citation: T. Holm et al., Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients, EUR HEART J, 22(5), 2001, pp. 428-436
Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients
Authors: Holm, T Berge, RK Andreassen, AK Ueland, T Kjekshus, J Simonsen, S Froland, S Gullestad, L Aukrust, P
Citation: T. Holm et al., Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients, TRANSPLANT, 72(4), 2001, pp. 706-711
Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure
Authors: Eiken, HG Oie, E Damas, JK Yndestad, A Bjerkeli, V Aass, H Simonsen, S Geiran, OR Tonnessen, T Christensen, G Froland, SS Gullestad, L Attramadal, H Aukrust, P
Citation: Hg. Eiken et al., Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure, EUR J CL IN, 31(5), 2001, pp. 389-397
Chemokines in myocardial failure - pathogenic importance and potential therapeutic targets
Authors: Aukrust, P Damas, JK Gullestad, L Froland, SS
Citation: P. Aukrust et al., Chemokines in myocardial failure - pathogenic importance and potential therapeutic targets, CLIN EXP IM, 124(3), 2001, pp. 343-345
Increase in anti-inflammatory cytokine levels in chronic heart failure: A measure of treatment success or failure? Response
Authors: Aukrust, P Gullestad, L Aass, H Fjeld, JG Wikeby, L Andreassen, AK Ihlen, H Simonsen, S Kjekshus, J Nitter-Hauge, S Ueland, T Froland, SS
Citation: P. Aukrust et al., Increase in anti-inflammatory cytokine levels in chronic heart failure: A measure of treatment success or failure? Response, CIRCULATION, 104(18), 2001, pp. E97-E98
Complement activation in patients with congestive heart failure - Effect of high-dose intravenous immunoglobulin treatment
Authors: Aukrust, P Gullestad, L Lappegard, KT Ueland, T Aass, H Wikeby, L Simonsen, S Froland, SS Mollnes, TE
Citation: P. Aukrust et al., Complement activation in patients with congestive heart failure - Effect of high-dose intravenous immunoglobulin treatment, CIRCULATION, 104(13), 2001, pp. 1494-1500
Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure
Authors: Gullestad, L Aass, H Fjeld, JG Wikeby, L Andreassen, AK Ihlen, H Simonsen, S Kjekshus, J Nitter-Hauge, S Ueland, T Lien, E Froland, SS Aukrust, P
Citation: L. Gullestad et al., Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure, CIRCULATION, 103(2), 2001, pp. 220-225
Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects
Authors: Holven, KB Holm, T Aukrust, P Christensen, B Kjekshus, J Andreassen, AK Gullestad, L Hagve, TA Svilaas, A Ose, L Nenseter, MS
Citation: Kb. Holven et al., Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects, AM J MED, 110(7), 2001, pp. 536-542
Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients
Authors: Holm, T Andreassen, AK Ueland, T Kjekshus, J Froland, SS Kjekshus, E Simonsen, S Aukrust, P Gullestad, L
Citation: T. Holm et al., Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients, AM J CARD, 87(6), 2001, pp. 815
Effect of metoprolol on cytokine levels in chronic heart failure - A substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF)
Authors: Gullestad, L Ueland, T Brunsvig, A Kjekshus, J Simonsen, S Froland, SS Aukrust, P
Citation: L. Gullestad et al., Effect of metoprolol on cytokine levels in chronic heart failure - A substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF), AM HEART J, 141(3), 2001, pp. 418-421
Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines
Authors: Holm, T Aukrust, P Andreassen, AK Ueland, T Brosstad, F Froland, SS Simonsen, S Gullestad, L
Citation: T. Holm et al., Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines, CLIN TRANSP, 14(3), 2000, pp. 218-225
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure - The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)
Authors: Hjalmarson, A Goldstein, S Fagerberg, B Wedel, H Waagstein, F Kjekshus, J Wikstrand, J El Allaf, D Vitovec, J Aldershvile, J Halinen, M Dietz, R Neuhaus, KL Janosi, A Thorgeirsson, G Dunselman, PHJM Gullestad, L Kuch, J Herlitz, J Rickenbacher, P Ball, S Gottlieb, S Deedwania, P
Citation: A. Hjalmarson et al., Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure - The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF), J AM MED A, 283(10), 2000, pp. 1295-1302
Postexercise ischemia is associated with increased neuropeptide Y in patients with coronary artery disease
Authors: Gullestad, L Jorgensen, B Bjuro, T Pernow, J Lundberg, JM Dota, CD Hall, C Simonsen, S Ablad, B
Citation: L. Gullestad et al., Postexercise ischemia is associated with increased neuropeptide Y in patients with coronary artery disease, CIRCULATION, 102(9), 2000, pp. 987-993
Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure
Authors: Damas, JK Eiken, HG Oie, E Bjerkeli, V Yndestad, A Ueland, T Tonnessen, T Geiran, OR Aass, H Simonsen, S Christensen, G Froland, SS Attramadal, H Gullestad, L Aukrust, P
Citation: Jk. Damas et al., Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure, CARDIO RES, 47(4), 2000, pp. 778-787
CXC-chemokines, a new group of cytokines in congestive heart failure - possible role of platelets and monocytes
Authors: Damas, JK Gullestad, L Ueland, T Solum, NO Simonsen, S Froland, SS Aukrust, P
Citation: Jk. Damas et al., CXC-chemokines, a new group of cytokines in congestive heart failure - possible role of platelets and monocytes, CARDIO RES, 45(2), 2000, pp. 428-436
Cardiopulmonary exercise testing and prognosis in severe heart failure: 14mL/kg/min revisited
Authors: Myers, J Gullestad, L Vagelos, R Do, D Bellin, D Ross, H Fowler, MB
Citation: J. Myers et al., Cardiopulmonary exercise testing and prognosis in severe heart failure: 14mL/kg/min revisited, AM HEART J, 139(1), 2000, pp. 78-84
Heart rate as a therapeutic target in heart failure
Authors: Kjekshus, J Gullestad, L
Citation: J. Kjekshus et L. Gullestad, Heart rate as a therapeutic target in heart failure, EUR H J SUP, 1(H), 1999, pp. H64-H69
Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure
Authors: Gullestad, L Aukrust, P Ueland, T Espevik, T Yee, G Vagelos, R Froland, SS Fowler, M
Citation: L. Gullestad et al., Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure, J AM COL C, 34(7), 1999, pp. 2061-2067
Effect of metoprolol CR XL in chronic heart failure: Metoprolol CR XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
Authors: Hjalmarson, A Goldstein, S Fagerberg, B Wedel, H Waagstein, F Kjekshus, J Wikstrand, J Hassle, A Westergren, G Hassle, A Thimell, M El Allaf, D Vitovec, J Aldershvile, J Halinen, M Dietz, R Neuhaus, KL Janosi, A Thorgeirsson, G Dunselman, P Gullestad, L Kuch, J Herlitz, J Rickenbacher, P Ball, S Gottlieb, S Deedwania, P Vandenhoven, G Novakova, I Danker, S Lundstrom, M Meyer-Sabellek, W Balla, I Sveinsdottir, M Dorhout, B Hildebrandt, A Szczurko, I Larsson, C Bucher, E Scott, E Dwyer, D Julian, DG DeMets, DL Chatterjee, K Feyzi, J Lehto, S Karpati, P Motz, W Samuelsson, O Viersma, JW Andersson, B Berthe, C Boutefeu, JM Boxho, G Decroly, P Derbaudrenghien, JP El Allaf, D Pirlet, J Henry, P Heyndrickx, G Missault, L Nannan, M Timmermans, P Vachiery, JL Van Mieghem, W Vandenbossche, JL Dvorak, K Herold, M Hradec, J Kana, A Petr, P Rybka, J Smid, J Svitil, P Toman, J Vitovec, J Agner, E Aldershvile, J Amtorp, O Egstrup, K Eliasen, P Gotzsche, CO Hildebrandt, P Johannesen, A Kaiser-Nielsen, P Nielsen, H Nielsen, PE Pedersen, F Nielsen, JR Skagen, K Halinen, M Honkanen, T Hussi, E Juvonen, J Jaaskelainen, H Rinne, J Salonen, T Andresen, D Berwing, H Dietz, R Forster, A Hauf, GF Krosse, B Luderitz, B von Olshausen, KE Schmailzl, KJG Schwimmbeck, PL Sigmund, M Voller, H Czuriga, I Hetey, M Janosi, A Katona, A Lengyel, M Nyaradi, A Rednik, A Sandori, K Szabo, P Tarjan, J Tenczer, J Timar, S Valyi, P Veress, G Zamolyi, K Oze, B Thorgeirsson, G Thorgeirsson, G Bernink, PJLM Bredero, AC Breedveld, RW Breuls, PNWM Bucx, JJJ Cornel, JH De Milliano, PAR Dunselman, PHJM Hamer, BJB Holwerda, NL Hoogsteen, J Hoorntje, JCA Kragten, JA Liem, AH Linssen, GCM Michels, HR Misier, ARR Schaafsma, HJ Sijbring, P Taverne, RJT Van Kempen, LHJ Van Stralen, R Van Veldhuisen, PJ Veerhoek, MJ Werter, CJPJ Wesdorp, JCL Willems, AR Withagen, AJAM Zwart, PAG Bjornerheim, R Dahle, M Dickstein, K Froland, GS Gullestad, L Gundersen, T Hofsoy, K Hole, TL Johansen, T Mannsverk, J Nesje, P Omland, TM Sjodin, C Smith, P Tjonndal, HA Vikesdal, O Waage, K Jaworska, K Kolodziej, P Kornacewicz-Jach, Z Krzeminska-Pakula, M Kuch, J Piotrowski, JW Piwowarska, W Stogowski, A Wodniecki, J Wrabec, K Ahlstrom, P Ekdahl, S Hemmingson, LO Herlitz, J Holmberg, L Lernfelt, B Nilsson, H Widgren, B Angman, K Erne, P Mohacsi, P Polikar, R Rickenbacher, P Schlapfer, H Batin, P Berkin, KE Callaghan, TS Forfar, J Frenneaux, M Greenbaum, RA Maltz, M Murdoch, D Reynolds, G Stephens, J Struthers, A Swan, J Tildesley, G Abbasi, A Alagona, P Alderman, J Alipour, M Anderson, JL Ansari, Z Ashraf, M Beanblossom, BT Bennett, S Benvenuti, D Berk, MR Bhalla, R Bilazarian, SD Browne, KF Buchter, CM Carlson, R Carlson, CJ Danisa, K Dauber, I DeWood, MA Deedwania, P Dennish, G Denny, DM DiBianco, R Diller, PM Dunlap, M Dowd, K Edmiston, A El Shahawy, M Elkayam, U Farnham, J Fenster, P Friedman, S Heywood, T Galichia, JP Geller, M Ghali, JK Gheorghiade, M Giles, T Gillespe, R Goldberg, G Goldberg, MC Goldscher, DA Gooden, GP Goodman, M Goodman, L Gorwit, J Gottlieb, SS Gradman, A Grech, D Hack, T Hall, JH Hattenhauer, MT Higginbotham, MB Hutchins, S Imburgia, M Iteld, BJ Jackson, B Jafri, S Jauch, W Jennison, S Kahn, BH Kao, W Kaplan, K Karlsberg, R Kennedy, HL Kennedy, JJ Kirkegaard, L Kraus, DH LaBresh, K Lalonde, L Lesser, MF Levites, R Levy, M Lewis, RK Loh, IK Madyoon, H Maislos, F Mann, D Maurice, GL Nisar, A Old, W Pappas, JD Phadke, K Promisloff, S Rashkow, AM Reeves, B Rosen, JH Rotman, M Saleem, T Savran, SV Shah, R Shalev, Y Shanes, JG O'Shaughnessy, M Silverman, B Steingart, RM Swenson, L Syed, K Thadani, U Thorsen, RD Tonkon, MJ Touchon, R Uhl, G Vaska, KJ Wagner, SG Weaver, CJ Weiss, RJ Wickemeyer, WJ Willens, HJ Wilson, JR Wright, R Yellen, L
Citation: A. Hjalmarson et al., Effect of metoprolol CR XL in chronic heart failure: Metoprolol CR XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF), LANCET, 353(9169), 1999, pp. 2001-2007
Interaction between lovastatin and cyclosporine A after heart and kidney transplantation
Authors: Gullestad, L Nordal, KP Berg, KJ Cheng, H Schwartz, MS Simonsen, S
Citation: L. Gullestad et al., Interaction between lovastatin and cyclosporine A after heart and kidney transplantation, TRANSPLAN P, 31(5), 1999, pp. 2163-2165
Risultati: 1-25 | 26-29